| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Alexandre Iannello | |
| Ali Ahmad | |||
| Olfa Debbeche | |||
| Suzanne Samarani | |||
| P2860 | cites work | Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA | Q22010440 |
| An activating immunoreceptor complex formed by NKG2D and DAP10 | Q22010441 | ||
| Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells | Q24290869 | ||
| Molecular analysis of NTB-A signaling: a role for EAT-2 in NTB-A-mediated activation of human NK cells | Q24300343 | ||
| IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors | Q24300426 | ||
| The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor | Q24306696 | ||
| Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule | Q24314704 | ||
| X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells | Q24676168 | ||
| Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G | Q24678795 | ||
| Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells | Q24683311 | ||
| Activation of NK cells by an endocytosed receptor for soluble HLA-G. | Q24813830 | ||
| KIR2DL4 (CD158d) genotype influences expression and function in NK cells | Q28155876 | ||
| Recognition of HLA-G by the NK cell receptor KIR2DL4 is not essential for human reproduction | Q28180558 | ||
| The influence of HLA genotype on AIDS | Q28202903 | ||
| KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential | Q28203519 | ||
| The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46 | Q28204339 | ||
| Cutting edge: induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells | Q28211347 | ||
| Expression of killer cell lectin-like receptor G1 on antigen-specific human CD8+ T lymphocytes during active, latent, and resolved infection and its relation with CD57 | Q28249061 | ||
| Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors | Q28259065 | ||
| Human diversity in killer cell inhibitory receptor genes | Q28259075 | ||
| What is the importance of the immunological synapse? | Q28261882 | ||
| HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C | Q28263511 | ||
| The biology of NKT cells | Q28277482 | ||
| A soluble form of the MHC class I-specific CD160 receptor is released from human activated NK lymphocytes and inhibits cell-mediated cytotoxicity | Q28284183 | ||
| Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor | Q28286015 | ||
| Natural killer type 2 bias in remission of multiple sclerosis | Q28359878 | ||
| KIR/HLA pleiotropism: protection against both HIV and opportunistic infections | Q28469038 | ||
| Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor | Q28505934 | ||
| Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice | Q28591835 | ||
| Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones | Q28610595 | ||
| MHC class I-independent recognition of NK-activating receptor KIR2DS4 | Q28610699 | ||
| Cutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation | Q28610728 | ||
| Detection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infection | Q28610733 | ||
| NK cell recognition | Q29615107 | ||
| Stepwise cytoskeletal polarization as a series of checkpoints in innate but not adaptive cytolytic killing | Q30478310 | ||
| Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells | Q32102035 | ||
| Augmentation of NK cell-mediated cytotoxicity to tumor cells by inhibitory NK cell receptor blockers | Q33198527 | ||
| HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1. | Q33262230 | ||
| Natural killer cells in antiviral defense: function and regulation by innate cytokines | Q33652468 | ||
| Regulation of immune responses through inhibitory receptors | Q33652541 | ||
| DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor | Q33911460 | ||
| Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection | Q33944628 | ||
| Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. | Q34056087 | ||
| Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum | Q34078591 | ||
| A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey | Q34160230 | ||
| Noncytolytic control of viral infections by the innate and adaptive immune response | Q34178107 | ||
| Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. | Q34178128 | ||
| Regulation of the natural killer cell receptor repertoire | Q34178144 | ||
| Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans | Q44078600 | ||
| Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals | Q45006277 | ||
| Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses | Q45345593 | ||
| The HLA-B*5703 allele confers susceptibility to the development of spondylarthropathies in Zambian human immunodeficiency virus-infected patients with slow progression to acquired immunodeficiency syndrome. | Q45527277 | ||
| Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. | Q46027985 | ||
| Interaction between KIR3DL1 and HLA-B*57 supertype alleles influences the progression of HIV-1 infection in a Zambian population. | Q46199343 | ||
| Cutting edge: KIR2DL4 transduces signals into human NK cells through association with the Fc receptor gamma protein | Q46391148 | ||
| Licensing of natural killer cells by host major histocompatibility complex class I molecules | Q46634172 | ||
| Genetic variants in nonclassical major histocompatibility complex class I human leukocyte antigen (HLA)-E and HLA-G molecules are associated with susceptibility to heterosexual acquisition of HIV-1. | Q46812188 | ||
| NK cell receptors | Q46858751 | ||
| Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production | Q47422836 | ||
| Functionally active HLA-G polymorphisms are associated with the risk of heterosexual HIV-1 infection in African women. | Q47747402 | ||
| Functional aberrant expression of CCR2 receptor on chronically activated NK cells in patients with TAP-2 deficiency | Q47759184 | ||
| HIV type 1 Tat protein inhibits interleukin 12 production by human peripheral blood mononuclear cells | Q47815336 | ||
| Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction | Q50335828 | ||
| Expression of KIR2DL1 on the entire NK cell population: a possible novel immunodeficiency syndrome. | Q51026937 | ||
| T cell- and B cell-independent adaptive immunity mediated by natural killer cells. | Q51983250 | ||
| CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. | Q51990042 | ||
| Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells. | Q51996024 | ||
| Antagonistic effect of NK cells on alternatively activated monocytes: a contribution of NK cells to CTL generation. | Q52009896 | ||
| NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis. | Q52576677 | ||
| Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B. | Q52842649 | ||
| Involvement of human natural killer cells in asthma pathogenesis: natural killer 2 cells in type 2 cytokine predominance. | Q52975538 | ||
| NK cells and human pregnancy--an inflammatory view. | Q53007013 | ||
| The activating NKG2D ligand MHC class I-related chain A transfers from target cells to NK cells in a manner that allows functional consequences. | Q53567361 | ||
| Cutting edge: cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression. | Q53903481 | ||
| Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulation. | Q53924361 | ||
| Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. | Q54432520 | ||
| Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals. | Q54543693 | ||
| Cutting Edge: Defective NK Cell Activation in X-Linked Lymphoproliferative Disease | Q56593901 | ||
| When killers become helpers | Q57083126 | ||
| Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia | Q57257278 | ||
| Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties. | Q38320280 | ||
| Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. | Q39104481 | ||
| Possible roles of KIR2DL4 expression on uNK cells in human pregnancy | Q40158701 | ||
| Allelic expression patterns of KIR3DS1 and 3DL1 using the Z27 and DX9 antibodies | Q40170826 | ||
| Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. | Q40191693 | ||
| Identification of distal KIR promoters and transcripts | Q40198207 | ||
| Release of MICB molecules by tumor cells: mechanism and soluble MICB in sera of cancer patients | Q40280283 | ||
| Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity | Q40323654 | ||
| A novel dendritic cell subset involved in tumor immunosurveillance | Q40323661 | ||
| Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance | Q40382191 | ||
| TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production. | Q40395254 | ||
| Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEA-related cell adhesion molecule 1. | Q40419886 | ||
| NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells. | Q40493871 | ||
| LFA-1 contributes an early signal for NK cell cytotoxicity. | Q40517797 | ||
| KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2). | Q40547461 | ||
| Self-reactive memory-phenotype CD8 T cells exhibit both MHC-restricted and non-MHC-restricted cytotoxicity: a role for the T-cell receptor and natural killer cell receptors. | Q40548951 | ||
| Human NKG2F is expressed and can associate with DAP12. | Q40556656 | ||
| Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users | Q40614184 | ||
| KIR2DL4 Is an IL-2-Regulated NK Cell Receptor That Exhibits Limited Expression in Humans but Triggers Strong IFN-γ Production | Q40633231 | ||
| Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors | Q40738490 | ||
| Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL. | Q40822163 | ||
| Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. | Q40900792 | ||
| Natural killer cell-mediated lysis of autologous cells modified by gene therapy | Q41853967 | ||
| Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene | Q42637807 | ||
| IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells | Q42678415 | ||
| Fas-mediated cytotoxicity by freshly isolated natural killer cells | Q42942845 | ||
| HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection | Q42986755 | ||
| Single-stranded RNA derived from HIV-1 serves as a potent activator of NK cells | Q43494949 | ||
| Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset | Q43600819 | ||
| Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression | Q43769019 | ||
| Cellular immune responses to HIV. | Q34223069 | ||
| MICA and MICB genes: can the enigma of their polymorphism be resolved? | Q34295071 | ||
| The LLT1 receptor induces IFN-gamma production by human natural killer cells | Q34315735 | ||
| Strategies for target cell recognition by natural killer cells | Q34341441 | ||
| Human natural killer cell receptors and co-receptors | Q34341459 | ||
| IL-15 and HIV infection: lessons for immunotherapy and vaccination | Q34434319 | ||
| Dicing and slicing: the core machinery of the RNA interference pathway | Q34458132 | ||
| Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction | Q34570127 | ||
| DAP12: an adapter protein with dual functionality | Q34581211 | ||
| Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect | Q34802287 | ||
| Human natural killer cell deficiencies and susceptibility to infection | Q35035745 | ||
| TGFbeta promotes conversion of CD16+ peripheral blood NK cells into CD16- NK cells with similarities to decidual NK cells | Q35652432 | ||
| HIV's evasion of host's NK cell response and novel ways of its countering and boosting anti-HIV immunity | Q35716737 | ||
| Synergy or independence? Deciphering the interaction of HLA Class I and NK cell KIR alleles in early HIV-1 disease progression | Q35753686 | ||
| HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. | Q35798486 | ||
| Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis. | Q35817615 | ||
| A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules | Q35847508 | ||
| Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity | Q35865986 | ||
| Different checkpoints in human NK-cell activation | Q35941923 | ||
| Immunogenetics of killer cell immunoglobulin-like receptors | Q35988375 | ||
| Associations between KIR epitope combinations expressed by HLA-B/-C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses | Q35988436 | ||
| Natural killer cells trigger differentiation of monocytes into dendritic cells | Q36007747 | ||
| HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A | Q36065870 | ||
| Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. | Q36191417 | ||
| Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function | Q36228467 | ||
| CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells | Q36229123 | ||
| Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes | Q36229197 | ||
| Viral strategies for evading antiviral cellular immune responses of the host | Q36276589 | ||
| NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. | Q36363753 | ||
| Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells | Q36375639 | ||
| The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity | Q36377146 | ||
| Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success | Q36399286 | ||
| Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis | Q36400442 | ||
| Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells | Q36401340 | ||
| Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. | Q36403556 | ||
| IL-18-induced CD83+CCR7+ NK helper cells | Q36403560 | ||
| How do natural killer cells find self to achieve tolerance? | Q36424804 | ||
| The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense | Q36528852 | ||
| Regulation of class I major histocompatibility complex receptor expression in natural killer cells: one promoter is not enough! | Q36652145 | ||
| NK cell regulation by SLAM family receptors and SAP-related adapters | Q36652149 | ||
| Bone marrow versus thymic pathways of natural killer cell development | Q36652153 | ||
| Human natural killer cell development | Q36652161 | ||
| Activation, coactivation, and costimulation of resting human natural killer cells | Q36652166 | ||
| Activation and self-tolerance of natural killer cells | Q36652183 | ||
| KIR and disease: a model system or system of models? | Q36652201 | ||
| Natural killer cells in viral infection: more than just killers. | Q36652221 | ||
| Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response | Q36732268 | ||
| NKT cells: T lymphocytes with innate effector functions | Q36788766 | ||
| Identification of bidirectional promoters in the human KIR genes | Q38304437 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV/AIDS | Q12199 |
| HIV | Q15787 | ||
| P304 | page(s) | 1-26 | |
| P577 | publication date | 2008-04-03 | |
| P1433 | published in | Journal of Leukocyte Biology | Q1524048 |
| P1476 | title | Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS. | |
| P478 | volume | 84 |
| Q38694446 | A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity. |
| Q33969383 | A dimeric form of the HIV-1 antibody 2G12 elicits potent antibody-dependent cellular cytotoxicity |
| Q40350795 | Activating KIRs alter susceptibility to pulmonary tuberculosis in a South African population. |
| Q45364508 | Alteration of inhibitory and activating natural killer cell receptor expression on T cells in human immunodeficiency virus-infected Chinese |
| Q38070411 | Anti-apoptotic mechanisms of HIV: lessons and novel approaches to curing HIV |
| Q36253312 | CD4+ T cell-dependent and CD4+ T cell-independent cytokine-chemokine network changes in the immune responses of HIV-infected individuals |
| Q34057778 | CD4+ T-cell help enhances NK cell function following therapeutic HIV-1 vaccination |
| Q52850729 | Cancer and the immune system: an overview. |
| Q38685785 | Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV. |
| Q35137038 | Coinfection with HIV-1 and HCV--a one-two punch |
| Q93223160 | Current status of potential therapeutic candidates for the COVID-19 crisis |
| Q33609877 | Decreased NK cell frequency and function is associated with increased risk of KIR3DL allele polymorphism in simian immunodeficiency virus-infected rhesus macaques with high viral loads |
| Q34009595 | Decreased infections in recipients of unrelated donor hematopoietic cell transplantation from donors with an activating KIR genotype |
| Q89529166 | Effects of 2-Week Exercise Training in Hypobaric Hypoxic Conditions on Exercise Performance and Immune Function in Korean National Cycling Athletes with Disabilities: A Case Report |
| Q52653716 | Effects of HIV infection and ART on phenotype and function of circulating monocytes, natural killer, and innate lymphoid cells. |
| Q36841139 | Epirubicin pretreatment enhances NK cell-mediated cytotoxicity against breast cancer cells in vitro |
| Q26864489 | Evasion from NK cell-mediated immune responses by HIV-1 |
| Q38365989 | Expression of chimeric receptor CD4ζ by natural killer cells derived from human pluripotent stem cells improves in vitro activity but does not enhance suppression of HIV infection in vivo. |
| Q58575859 | Expression of the Inhibitory Receptor TIGIT Is Up-Regulated Specifically on NK Cells With CD226 Activating Receptor From HIV-Infected Individuals |
| Q36077824 | Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and HCV/HIV Co-Infection and Do Not Recover during Therapy |
| Q46915185 | Genetic variations in loci relevant to natural killer cell function are affected by ethnicity but are generally not correlated with susceptibility to HIV-1. |
| Q43013123 | Glial transcripts and immune-challenged glia in the suprachiasmatic nucleus of young and aged mice |
| Q41865397 | HIV infection is associated with a preferential decline in less-differentiated CD56dim CD16+ NK cells |
| Q35076703 | Human immunodeficiency virus type 1 infection is associated with increased NK cell polyfunctionality and higher levels of KIR3DL1+ NK cells in ugandans carrying the HLA-B Bw4 motif |
| Q39641765 | Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms |
| Q34070433 | Innate Immune Natural Killer Cells and Their Role in HIV and SIV Infection |
| Q54261918 | Insulin-like growth factor-1 receptor (IGF-1R) inhibition promotes expansion of human NK cells which maintain their potent antitumor activity against Ewing sarcoma cells. |
| Q33827994 | KIR-HLA and maternal-infant HIV-1 transmission in sub-Saharan Africa |
| Q34275424 | Mucosal immunity in the female genital tract, HIV/AIDS |
| Q33905807 | Multiple KIR gene polymorphisms are associated with plasma viral loads in SIV-infected rhesus macaques |
| Q37931256 | NK cells and their receptors during viral infections |
| Q36453421 | NK cells in healthy aging and age-associated diseases |
| Q41923989 | NKG2C+NKG2A- Natural Killer Cells are Associated with a Lower Viral Set Point and may Predict Disease Progression in Individuals with Primary HIV Infection |
| Q89909976 | Nanomaterials for modulating innate immune cells in cancer immunotherapy |
| Q42282419 | Natural Killer Cells - Their Role in Tumour Immunosurveillance |
| Q35751024 | Natural Killer p46 Controls Hepatitis B Virus Replication and Modulates Liver Inflammation |
| Q42123726 | Natural killer cells recognize friend retrovirus-infected erythroid progenitor cells through NKG2D-RAE-1 interactions In Vivo |
| Q39865381 | Potential role of interleukin-18 in the immunopathogenesis of AIDS: involvement in fratricidal killing of NK cells |
| Q51671816 | Selection of an optimal treatment method for acute periodontitis disease. |
| Q39677106 | Siglec-7 Defines a Highly Functional Natural Killer Cell Subset and Inhibits Cell-Mediated Activities |
| Q38200088 | TLR/NCR/KIR: Which One to Use and When? |
| Q56916580 | The battle between infection and host immune responses of dengue virus and its implication in dengue disease pathogenesis |
| Q34344617 | c-Myc regulates expression of NKG2D ligands ULBP1/2/3 in AML and modulates their susceptibility to NK-mediated lysis |
Search more.